SCHEMBL6563455

SCHEMBL6563455

Cc1ccc(C(=O)NCCc2ccccc2)cc1C#CCNc1ccc(C(=N)NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.41
NPC1 O15118 8/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NAMPT P43490 1/20 0.40
CTSK P43235 1/20 0.40
SYK P43405 1/20 0.39
HDAC8 Q9BY41 2/20 0.39
KDM5B Q9UGL1 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 2/20 0.38
ESRRG P62508 2/20 0.38
TP53 P04637 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561961 0.85 MLYCD (0.39) RAB9ANPC1NAMPTCTSKLMNA
SCHEMBL6563699 0.84 RAB9A (0.47) RAB9ANPC1SMN1; SMN2L3MBTL1SYK
SCHEMBL6565333 0.83 MEN1 (0.40) SMN1; SMN2LMNA
SCHEMBL6563537 0.82 PLAU (0.38) RAB9ANPC1
SCHEMBL6565428 0.77 MEN1 (0.34) RAB9ANPC1SMN1; SMN2L3MBTL1TP53
SCHEMBL6565309 0.77 PTPN11 (0.34)
SCHEMBL6563355 0.77 PTPN11 (0.47) CTSKLMNA
SCHEMBL6563932 0.77 HTT (0.34) RAB9ANPC1
SCHEMBL6563229 0.76 PLAU (0.37) RAB9ANPC1
SCHEMBL6563741 0.76 AAK1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed
US-6479524-B1 TO PROLONG THE THROMBIN TIME BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-11-12 US disclosed